Transmission and prevention: latest news

Transmission and prevention resources

Transmission and prevention features

Transmission and prevention in your own words

  • Bored and horny

    It’s Sunday afternoon and it’s raining. I’m bored and horny. However, I’ve got £20 left over from the night before and this will be enough...

    From: In your own words

Transmission and prevention news from aidsmap

More news

Transmission and prevention news selected from other sources

  • Generic PrEP approved, but not soon available

    The U.S. Food and Drug Administration has approved the first generic version of Truvada, a combination pill used for both HIV treatment and prevention, but it will not soon hit pharmacy shelves, advocates said.

    17 June 2017 | Bay Area Reporter
  • Top HIV expert is not donating to crowdfunding HIV vaccine campaign, says it's "Fake News"

    Dr. Carl W. Dieffenbach, head of the AIDS division of the US National Institutes of Health, has denounced an HIV vaccine crowdfunding campaign involving prominent stars. The major fundraising #ENDHIV campaign which features SIA, the campaign’s ambassador. Other celebrities include Zoe Saldana and Julianne Moore. Dr Dieffenbach's assessment is not pointed at the celebrities nor the organisation behind the campaign. It’s about the research of scientist, Dr. Paul, whom Dieffenbach asserts “is wrong” in his direction towards discovering the vaccine or cure promoted by the video and the campaign’s website www.endhiv.com. Yet, the #ENDHIV video calls Dr. Paul’s work “a promising new AIDS cure.”

    17 June 2017 | imstilljosh
  • PrEP 17 – The coming of age of PrEP

    PrEP17 explores the stories of over a dozen PrEP activists; current and former PrEP users; clinicians; and policy-makers. The 36 minute documentary film, commissioned by PrEPster, shines a light on how PrEP has become available to thousands of people, despite the failures of the health system.

    26 May 2017 | Prepster
  • Melbourne man tests positive to HIV while taking preventative drug

    A man has tested positive to HIV at a Melbourne clinic while participating in a trial of PrEP, an antiretroviral drug credited with preventing the spread of the disease. It's understood just over a week ago, he tested positive to HIV at a Melbourne clinic. On Monday, a spokesman at The Alfred confirmed researchers were "reviewing the clinical details of a man who has tested positive to HIV while being a registered participant of the Victorian PrEPX study."

    22 May 2017 | The Age (Melbourne)
  • Open letter to Gilead Sciences about PrEP by EATG and the PrEP in Europe Initiative

    Please read and share this letter signed by the European AIDS Treatment Group and the PrEP in Europe Initiative (PEI), a partnership of European prevention and policy NGOs. It requests Gilead Sciences to surrender their patent of Truvada® or otherwise make it possible for Truvada or generic equivalents of it to be offered at greatly reduced prices to all European health care systems so that it can be used as HIV pre-exposure prophylaxis (PrEP).

    18 April 2017 | EATG / PrEP in Europe
  • The real sex lives of gay men - GMFA's biggest survey

    GMFA has just conducted its biggest-ever sex survey for the 150th edition of its resource FS. Ian Howley, Chief Executive of GMFA, said: “With over 3,000 responses it gives a fascinating snapshot of the kind of sex that gay and bisexual men in the UK are having, what they enjoy and what they are doing, or not doing, to maintain their sexual health.”

    13 April 2017 | GMFA
  • Where Is PrEP? HIV Charities Warn The NHS Will Miss Its Own Deadline

    Britain's top HIV organisations have accused NHS England of dragging its feet in providing the prevention drug, despite 17 people a day contracting the virus.

    30 March 2017 | BuzzFeed
  • HIV Activist Learning Modules: Engaging our Community in HIV Prevention Policy Advocacy

    In order to support the efforts of prevention advocates across the United States, Treatment Action Group has developed a series of modules to help support activists’ capacity needs and to develop advocacy action plans. The slides and handouts in each module focus on how to identify and change the governmental, organizational, and institutional policies that create roadblocks to comprehensive HIV prevention in our communities. The materials are useful for personal education or group discussion on HIV prevention and policy advocacy.

    29 March 2017 | TAG
  • Welsh report says HIV prevention drug 'highly effective'

    PrEP has "clear potential" to prevent people catching the virus, a Welsh Government-commissioned report has said. It is not currently available on the Welsh NHS.

    22 March 2017 | BBC
  • Breastfeeding with an undetectable viral load: what do we know?

    Megan DePutter on why undetectable does not equal untransmittable in the case of breastfeeding, but why women should be supported to make an informed choice anyway.

    08 March 2017 | Positive Lite
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.